Danaher Corporation (DHR)
NYSE · Healthcare · Medical - Diagnostics & Research
Profile
Danaher Corporation
- Exchange
- NYSE
- Ticker
- DHR
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- US
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
Key facts
Danaher Corporation: key facts
- Danaher Corporation (NYSE: DHR) is a Medical - Diagnostics & Research company in the Healthcare sector.
- In fiscal 2025, Danaher Corporation reported revenue of $24.6B and net income of $3.6B.
- Revenue fell 4.4% a year over the last 4 fiscal years.
- Free cash flow was positive in 5 of the last 5 fiscal years.
- Net income was positive in 5 of the last 5 fiscal years.
- Over the last twelve months, revenue was $25.6B and net income was $4.3B.
MonkScore
Danaher Corporation's MonkScore
MonkScore
MonkScore range: 40–50
as of October 2026
Sector rank: 413 of 628 in Healthcare
How this score is madeDisclaimer
Pillar ranges
- Growth10–20
- Profitability40–50
- Quality40–50
- Market Conviction80–90
- Safety20–30
The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–10 to 90–100.
Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.
Fundamentals
Figures from the statements
Danaher Corporation's annual figures and the last twelve months, in USD. Last report: 25 September 2026.
| Figure | Last 12 months | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $25.6B | $24.6B | $23.9B | $23.9B | $26.6B | $29.5B |
| Gross profit | $15.0B | $15.0B | $14.2B | $14.0B | $16.2B | $18.0B |
| Operating income | $5.2B | $5.1B | $5.2B | $5.3B | $7.5B | $8.1B |
| Net income | $4.3B | $3.6B | $3.9B | $4.8B | $7.2B | $6.4B |
| Operating cash flow | $6.9B | $6.4B | $6.7B | $7.2B | $8.5B | $8.4B |
| Capital expenditure | -$1.1B | -$1.2B | -$1.4B | -$1.4B | -$1.2B | -$1.3B |
| Free cash flow | $5.7B | $5.3B | $5.3B | $5.8B | $7.4B | $7.1B |
| Total debt | $26.5B | $18.4B | $17.1B | $19.5B | $20.6B | $23.3B |
| Cash | $5.7B | $4.6B | $2.1B | $5.9B | $6.0B | $2.6B |
Revenue growth a year
- 1-year
- 2.9%
- 3-year
- -2.7%
- 4-year
- -4.4%
Compound growth between fiscal years.
Peers
Similar companies
- RadNet, Inc.NASDAQ:RDNTMonkScore range: 40–50
- Revvity, Inc.NYSE:RVTYMonkScore range: 40–50
- Myriad Genetics, Inc.NASDAQ:MYGNMonkScore range: 50–60
- Charles River Laboratories International, Inc.NYSE:CRLMonkScore range: 50–60
- NeoGenomics, Inc.NASDAQ:NEOMonkScore range: 50–60
- Qiagen N.V.NYSE:QGENMonkScore range: 50–60
- Labcorp Holdings Inc.NYSE:LHMonkScore range: 50–60
- Waters CorporationNYSE:WATMonkScore range: 60–70
Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click
MonkStreet provides research, not investment advice.
Page built on 31 October 2026.